Veradermics, Incorporated (MANE) Institutional Ownership & Insider Trading
164 institutions reported holding Veradermics, Incorporated shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 42 insider trades on Form 4 since 2025-10-01.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
MANEVeradermics, IncorporatedFollow MANE — free
—
Price chart with a free account
- Market cap
- 5.8B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 12 Nov, in 18 days
Institutions · all 13F filers
quarter to 30 Jun 2026 · filers in both quarters164 institutions held 81.6% of the shares. Across filers that reported both quarters, shares held changed +30.7%.
Largest moves, shares (millions)
Institutional flow by quarter
net shares added or trimmed, millions · filers in both quarters| Quarter | Holders | Shares held, M | Change | Increased | New | Decreased | Closed |
|---|---|---|---|---|---|---|---|
| Jun 26 | 164 | 34 | +30.7% | 41 | 94 | 17 | 13 |
| Mar 26 | 81 | 26 | — | — | — | — | — |
Veradermics, Incorporated — questions
- Who owns Veradermics, Incorporated stock?
- 164 institutions reported Veradermics, Incorporated shares in 13F filings for the quarter ended 2026-06-30. The largest: SUVRETTA CAPITAL MANAGEMENT, LLC (10.0%), FMR LLC (7.7%), SR One Capital Management, LP (5.8%).
- Are Veradermics, Incorporated insiders buying or selling?
- 42 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.
Every figure on this page comes from Veradermics, Incorporated's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.